Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood ...

Topline data for the once-daily PKR activator etavopivat demonstrate a 27% reduction in vaso-occlusive crises and a robust hematologic response in patients with SCD.

Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...

AND017 is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor. The Food and Drug Administration has granted Orphan Drug designation to KIND Pharmaceutical’s AND017 for the ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Hydroxyurea conferred benefit to children and adults with hemoglobin SC disease, according to study ...

In neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson’s, and Alzheimer’s, healthy brain cells are damaged by aberrant reactive oxygen species (ROS). A potential ...

Risk peaked when anemia occurred alongside abnormal Alzheimer's biomarkers ...

Background: British Columbia introduced a preadolescent hepatitis B (HB) immunization program in 1992. This study documents trends in the reported rate of acute HB disease since 1992 and examines ...

In neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS, excessive H2O2 from reactive astrocytes triggers a vicious cycle of oxidative stress, protein aggregation, and neuronal loss.

The MarketWatch News Department was not involved in the creation of this content. New Research Confirms Hb Variant Test for Sickle Cell, Gazelle(TM), Useful for Screening and Tracking Treatment ...

Hemoglobin, long celebrated for ferrying oxygen in red blood cells, has now been revealed to play an overlooked—and potentially game-changing—antioxidant role in the brain. "The key was to uncover ...